Dyne Therapeutics, Inc.
DYN
$25.70
-$0.26-1.00%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -47.75% | -7.95% | -3.62% | 2.54% | 3.90% |
| Total Depreciation and Amortization | 1.82% | 5.57% | -0.38% | 3.98% | 0.20% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 14.66% | 19.17% | 0.40% | 8.58% | -20.35% |
| Change in Net Operating Assets | 187.18% | -232.62% | -292.76% | 4.02% | 256.61% |
| Cash from Operations | 10.10% | -29.59% | -23.19% | 4.14% | 10.57% |
| Capital Expenditure | -585.07% | 54.34% | 97.48% | -31,875.00% | 93.88% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -51.13% | -248.09% | 107.81% | -374.80% | 180.20% |
| Cash from Investing | -100.46% | -343.58% | 102.59% | -660.45% | 364.61% |
| Total Debt Issued | 794.46% | -86.28% | -- | -100.00% | -- |
| Total Debt Repaid | -474.27% | -- | -- | -- | -- |
| Issuance of Common Stock | -43.78% | -99.66% | 75.11% | 10,948.48% | -98.60% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 100.00% | -4,944.44% | 98.36% | -- | -- |
| Cash from Financing | 722.62% | -98.36% | 98.30% | 115.66% | -28.65% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 45.12% | -143.81% | 261.37% | 589.63% | -65.10% |